Coronary Vasospasm
13
1
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
23%
3 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
The DISCOVER INOCA Prospective Multi-center Registry
Multicenter Registry on Microvascular Dysfunction - Searching a New Ach Spasm Definition
CORonary MICrovascular Angina (CorMicA)
The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)
Effect of Glucose on Ocular Blood Flow
Abnormal Coronary Vasomotion in Patients With Suspected Coronary Artery Disease (CAD)
Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial
Advanced Invasive Diagnosis for Patients With Chronic Coronary Syndromes Undergoing Coronary ANGIOgraphy (AID-ANGIO)
EUROpean Coronary microCirculatory Resistance and Absolute Flow Trial
The Effect of Nebivolol in Hypertensive Patients With Coronary Arterial Spasm
Therapeutic Effect of Sildenafil in Patients With Coronary Vasospasm
Coronary Spasm Presenting Aborted Sudden Cardiac Death, the Multicenter Registry
Endothelial Dysfunction and Coronary Artery Spasm